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1. Introduction 
Several minor hemoglobin components in normal 
human erythrocytes have been described [2]. The 
most prominent of these, HbALc, is presented as 
4-60/o of total hemoglobin in normal red blood cells. 
In erythrocytes of patients with diabetes consider- 
ably larger amounts have been found [3,4]. The 
amino acid sequence of HbAfc is identical to that 
of HbA, but both the N-terminal o-amino groups of 
the P-chains are blocked by a carbohydrate residue 
containing a linkage reducible by sodiumborohydride 
[5,6]. The pK of this group is -6.65 [5] . These 
results indicated the bond to be a Schiff base which, 
however, proved stable even at pH 4.0 [5]. The 
blocking group has a mass spectrum compatible with 
a hexose [5], but both the anthrone test and the 
phenol test for reducing sugars are negative [4]. 
The present study was undertaken to determine 
the structure and synthetic pathway of HbAfc. 
2. Materials and methods 
2.1. General 
All chemicals used were reagent grade, radio- 
actively labeled compounds were purchased from the 
Radiochemical Centre in Amersham, England. 
2.2. Hemoglobin preparation 
Blood from male volunteers or animals was drawn 
using heparin as an anticoagulant. The red cells 
were washed with saline and lysed with 5 vol. of 
*Part of the material reported here has been presented at 
the USGEB Meeting in Fribourg in April 1976 [ 1). 
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0.01 M phosphate buffer, pH 6.8, containing low4 M 
EDTA. After dialysis against the same buffer the 
hemolysate was freed from debris by centrifugation. 
The various hemoglobins were separated on a CM- 
Sephadex column (25 X 400 mm for 0.5-3.0 g 
hemoglobin), equilibrated with the above dialysis 
buffer. The elution was carried out by a gradient 
going from 0.01 M phosphate pH 6.8 (2: 1) to 0.02 M 
disodium phosphate (2: 1) [7]. Quantitation of 
HbALc was done by planimetry of the individual 
hemoglobin peaks obtained from spectrophotometric 
readings at 540 nm of all fractions of the chromato- 
grams. 
Purity was assessed by electrophoresis on Cellogel 
strips (12 h at 150 V) in a system consisting of 6 M 
urea in 0.04 M phosphate buffer pH 6.6 containing 
0.05 M fl-mercaptoethanol. The strips were stained 
for 15 min with Ponceau S (0.5 g/100 ml 5% TCA) 
and destained with 5% v/w acetic acid. The strips 
were cut into portions which were individually 
dissolved in 1 ml 80% acetic acid, and radioactivity 
was counted as follows: 1 ml of sample was mixed 
with 2 ml of a 1: 1 toluene-isopropanol mixture. 
After 10 min 0.2 ml HzOz 30% was added and 
after a further 40 min standing at room temperature 
15 ml of a 9: 1 mixture of instagel-5 N HCl was 
added. The same sample preparation was used for 
column effluents. Counting was done on a Packard 
B 2450 LSC scintillation counter. 
2.3. Incubations 
Whole blood was incubated at 37% for up to 20 h 
after adding uniformly labeled [14C]glucose mixed 
with unlabeled glucose to give a final concentration 
of 10 mg/ml. 
Purified hemoglobin was incubated for 8-l 8 h 
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in either its O2 or CO form at a concentration of 
4-10%. Buffers used were 0.01 M phosphate in the 
range of 6.0-8.0; Tris 0.1 M, pH 7.9; and 0.1 M Bis- 
Tris, pH 5.1-7.3. 
2.4. Product analysis 
Native HbATc and the analogous products from 
incubations were reduced with sodium borohydride 
[7]. a- and p- c ams were spearated [8] and subse- h . 
quently aminoethylated [9]. Tryptic peptide mapping 
and staining was done in the usual manner as describ- 
ed by Lehmann and Huntsman [lo] . The resulting 
peptide spots were ringed with pencil and the finger- 
print destained in a HsOs saturated atmosphere. The 
peptide spots were cut out and counted in toluene 
containing 8 g butyl-BDP per litre. The thiobarbi- 
turic acid (TBA) reaction for determining the presence 
of 5hydroxymethylfurfural was done as follows: 
1 ml of a 1% globin from HbATc solution was mixed 
with 0.5 ml 0.3 N oxalic acid and heated for 1 h in a 
boiling water bath. After cooling to room temperature, 
0.5 ml of 40% TCA was added and the resulting 
precipitate removed by filtration. After addition of 
0.5 ml 0.05 TBA. the mixture was incubated at 40% 
for half an hour. Spectra obtained on these samples 
were typical of 5-hydroxymethyl-furfural with an 
e,,at443nm [ll]. 
3. Results 
Incubation of whole blood and hemolysates in 
the presence of high concentrations of glucose results 
in an increase in HbATc. When isolated HbA is 
incubated with glucose, a hemoglobin derivative is 
formed which is chromatographically indistinguish- 
able from HbATc [ 11. This hemoglobin has a P-chain 
with the electrophoretic properties of the &chain 
obtained from natural HbATc. 
When the incubations were carried out with 14C- 
labeled glucose, the resulting hemoglobin derivative 
had between 2.0 and 2.4 moles of labeled glucose 
bound per tetramer (table 1). Also given in table 1 
are the amounts of HbATc formed at two different 
incubation times and glucose to hemoglobin ratios. 
When either natural or synthetic HbATc was treated 
with oxalic acid, 5-hydroxymethylfurfural was 
released from the protein, and could be detected by 
the colour reaction with 2-thiobarbituric acid. A 
sample of synthetic HbATc resulting from the incuba- 
tion of [r4C] glucose with HbA and having a specific 
activity of 35 10 cpm/mg was separated into its 
component polypeptide chains by electrophoresis as 
described in Materials and methods. 0.1 mg of the 
labeled protein was applied to the strip. 310 cpm 
were associated with the &chain band and only 34 
cpm with the o-chain band, thus showing that almost 
10 times more glucose was bound to P-chains. Tryptic 
fingerprints of glucose labeled fl chains after reduction 
with NaBH4 [6] revealed the absence of a normal 
/3Tp-I peptide, but the presence of a peptide in the 
position of the /3Tp-I from natural similarly treated 
HbAIc was observed. Of the total of 430 cmp 
recovered from the entire fingerprint 395 cpm 
Table 1 
Incubation of HbA with labeled glucose at 37”C, pH 7.4 
Incubation time 
8h 18h 
Buffer (M) 
CO-Hb (mM) 
Glucose (Glc) (mM) 
Ratio (Glc)/(Hb) 
Specific radioactivity of glucose 
(&i/mmol) 
Specific radioactivity of HbAIc 
OcCijmmol) 
Ratio Glc/HbA1, 
% H~AI~ formed 
0.05 Bis-Tris 0.01 PO, 
0.15 0.8 
55 55 
366 69 
227 460 
550 910 
2.4 2.0 
4.7 4 
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Fig.1. Chromatogram of HbA on CM-Sephadex after 
incubation with 1000 mg [“C]glucose in 0.1 M phosphate 
buffer, pH 7.4, 37”C, 15 h. (- - - - -) cpm/ml effluent X 10” 
( -_) GD540mn 
migrated with the peptide PAIcTp-I. The remaining 
counts were distributed among several peptides. Thus, 
over 90% of the label was found in the N-terminal 
peptide. Figure 2 illustrates the strong dependence 
of the reaction on pH. Table 2 shows that the reac- 
Fig.2. % HbALc formed in 8 h as function of pH. For 
conditions see text. (0) Phosphate 0.01 M. (m) Tris 0.1 M. 
(A) Bis-Tris 0.1 M. (- - - -) Titration curve of the e-amino 
group of o-chains in CO-hemoglobin from ref. [ 131. 
Table 2 
Compounds analogous to HbAIc 
Hemoglobin N-terminal in vivo 
sequence present 
in vitro 
synthetized 
HbA W-His + + 
HbAJHbS W-His + 
Hb mouse oboba V&His + ndb 
Hbf,Hbs horse Val-Gln + + 
HbcatB Gly-Phe + + 
aobese mice suffering from diabetes 
bnd = not done 
tion is not specific for human HbA and does not 
depend upon the N-terminal sequence. Products 
analogous to HbAIc were obtained with other hexoses 
(rhamnose, glucosamine, N-acetyl glucosamine, 
fructose-6-phosphate). 
When red blood cells were incubated with either 
D- [2-3H]glucose or D- [5-3H] glucose of identical 
specific activities, 3.% HbAIc was synthesized de 
novo in both incubations. In the case of glucose 
labeled in the 5 position this hemoglobin had a 
specific activity of 67 1 cpm/mg. In contrast, in the 
incubation with glucose labeled in the 2 position the 
specific activity was only 369 cpm/mg of HbAIc. 
These results indicate in the loss of label from 
position 2 implying the intracellular occurrence of the 
Amadori rearrangement. A current scheme of the 
reaction sequence in the Amadori rearrangement is 
given in fig.3. 
4. Discussion 
Our results clearly demonstrate the non-enzymic 
nature of the reaction of glucose with the B-N- 
terminal amino group of hemoglobin. This is indepen- 
dent of the N-terminal sequence. Contamination of 
our hemoglobin samples with an as yet unknown 
enzyme is unlikely, since the reaction occurred with 
hemoglobins differing widely in their chromatographic 
properties. Such a non-enzymatic reaction has been 
postulated recently by Bunn et al. [ 121. This 
reaction is strongly pH-dependent and in view of the 
nucleophilic attack on the carbohydrate by the un 
protonated amino group is a function of the pK of 
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H2 
0 e HO OH OH l RNb 
OH 
aucose aminogroup 
Hoe + HoeNR 
OH 
Glucosylamine Schiif’base 
iAm3dori rearrangement 
t 
5-+.iF* RN@ 
Fig.3. Simpmed scheme of the proposed reaction sequence involved in the formation of HbAIc and the subsequent Amadori 
rearrangement. 
amino group involved. Therefore, this reaction must 
be very general in nature, both in respect to the amino 
groups and the carbohydrates, depending on the pK 
of the amino group involved. This generality of the 
reaction implies a wide significance in biological 
systems and in diabetes specifically. In the case of 
erythrocytes, these carbohydrates are most likely the 
metabolic derivatives of glucose. 
That other groups can similarly react, albeit to a 
lesser extent, is evidenced by some incorporation of 
radioactivity into HbA without change of chromato- 
graphic properties (fig.1). The pH dependence of 
the reaction illustrated in fig.2 strongly favors hemo- 
globin as a reactant in view of the relatively low pK 
values of its N-terminal a-amino groups in both the 
R- and the T-state (table 3). This feature is, however, 
not able to explain the very high specificity of the 
reaction for the P-chain. This is particularly true, 
since our incubations were done with the CO or O2 
derivative of HbA (see table 3). 
The structure of the N-terminal blocking group is 
most easily rationalized by the formation of an IV- 
glycoside in equilibrium with a Schiff base [ 141. The 
evidence for this is reviewed in the introduction. Both 
the formation of 5hydroxymethylfurfural and the 
experiments with D-[2-3H]glucose provide strong 
evidence that the initial product undergoes the 
Amadori rearrangement even intra-erythrocytically 
(see fig.3). Similar conclusions were reached by Bunn 
et al. [15] using a somewhat different approach. 
Finally, it needs to be pointed out that the course of 
the off-reaction obtained by the incubation of [‘*Cl- 
glucose-labeled HbAIc in the presence of a high 
concentration of non-labeled glucose proceeds very 
slowly. In fact, non protein-bound radioactivity 
appeared very slowly in the TCA supernatant obtain- 
ed after various incubation times. This is in agreement 
Table 3 
pK values of N-terminal amino groups 
Compound PK Methoda 
Hemoglobin-CO <OL 
Hemoglobin-CO fl 
Hemoglobin-deoxy Q 
Hemoglobin-deoxy p 
aC: Cyanate reaction [ 131 
6.95 C 
7.05 C 
7.79 C 
6.84 C 
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with recent in vivo observations on diabetics [ 161 
showing that HbAIc levels decreased after normalisa- 
tion of blood sugars at a rate at which the erythro- 
cytes were replaced by newly formed cells. 
[71 
WI 
191 
[lOI 
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